Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Personalized Arrhythmic Risk Stratification for Sudden Cardiac Death in Ischemic, Non-ischemic, and Hypertrophic Cardiomyopathy Patients: The Two-Step, Non-invasive Risk Factors Guiding to Electrophysiology Study Approach

Version 1 : Received: 30 August 2023 / Approved: 31 August 2023 / Online: 1 September 2023 (03:36:09 CEST)

How to cite: Arsenos, P.; Kordalis, A.; Dilaveris, P.; Doundoulakis, I.; Antoniou, C.; Laina, A.; Milaras, N.; Xintarakou, A.; Tsiachris, D.; Sideris, S.; Toutouzas, K.; Tsioufis, K.; Gatzoulis, K.A. Personalized Arrhythmic Risk Stratification for Sudden Cardiac Death in Ischemic, Non-ischemic, and Hypertrophic Cardiomyopathy Patients: The Two-Step, Non-invasive Risk Factors Guiding to Electrophysiology Study Approach. Preprints 2023, 2023082203. https://doi.org/10.20944/preprints202308.2203.v1 Arsenos, P.; Kordalis, A.; Dilaveris, P.; Doundoulakis, I.; Antoniou, C.; Laina, A.; Milaras, N.; Xintarakou, A.; Tsiachris, D.; Sideris, S.; Toutouzas, K.; Tsioufis, K.; Gatzoulis, K.A. Personalized Arrhythmic Risk Stratification for Sudden Cardiac Death in Ischemic, Non-ischemic, and Hypertrophic Cardiomyopathy Patients: The Two-Step, Non-invasive Risk Factors Guiding to Electrophysiology Study Approach. Preprints 2023, 2023082203. https://doi.org/10.20944/preprints202308.2203.v1

Abstract

Arrhythmic sudden cardiac death (SCD) has an annual prevalence of 1 per 1000 while 75% of the victims suffer from ischemic and 10% from non-ischemic or hypertrophic cardiomyopathy. Altogether, these three entities account for more than 80% of the total SCD victims. Guidelines for implantable cardiac defibrillators are still dominated by LVEF<30% from the MADIT II study. In terms of arrhythmic risk stratification, the PRESERVE-EF study restored in clinical practice the two-step arrhythmic risk stratification approach based on Electrocardiographic non-invasive risk factors (NIRFs) guiding to electrophysiological study. In our times with the multiple cardiac imaging methods and artificial intelligence applications availability, this two-step approach based on integrated arrhythmia mechanisms detection, emerges as an efficient SCD risk stratification paradigm for these three entities but also for the patients with congenital heart disease.

Keywords

arrhythmic sudden cardiac death; risk stratification; non-invasive risk factors; NIRFs; electrophysiology study; two-step approach; cardiomyopathy

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.